Page 1 of 4 No. RJH – SET 12/2017 11 Aug 2017 Subject : Management Discussion and Analysis for the 2nd Quarter of 2017 ending on 30 June 2017 To : The President The Stock Exchange of Thailand

Exchange of Thailand The Board of Directors Meeting of Wattanapat Hospital Trang Public Company Limited (the “Company”) No. 3/2017, held on February 26, 2017, approving the audited consolidated financial

: The President The Stock Exchange of Thailand Takuni Group Public Company Limited (The Company) and its subsidiaries (The Group) has sales and service income for 9 months ended 30 September 2017

Attention: The President The Stock Exchange of Thailand Takuni Group Public Company Limited (The Company) and its subsidiaries (The Group) would like to clarify the change in operating result for the 3 months

- Translation - Ref. J61/001 22 February 2018 Subject: Management Discussion and Analysis for Yearly Ending 2017 To: President The Stock Exchange of Thailand Pursuant to JAS Asset Public Company Limited (the

: Management Discussion and Analysis for Yearly Ending 2017 (Edited) To: President The Stock Exchange of Thailand Pursuant to JAS Asset Public Company Limited (the “Company”) Board of Meeting No.1/2018 on 22

Microsoft Word - NWR 030_E_Year18 (Translation) No.FN-NWR 030/2562 28 February 2019 Subject : Submission of Financial Statements for the Years ended 31 December 2018 To : President The Stock Exchange

. DOD017/2562 May 8, 2019 Re: Management’s Discussion and Analysis (MD&A) of the Consolidated Financial Results for Quarter 1 of 2019 To: The President The Stock Exchange of Thailand DOD Biotech Public

: President The Stock Exchange of Thailand Pursuant to JAS Asset Public Company Limited (“the Company”) Meeting Resolution No. 6/2019 on 6 August 2019, the resolution to certify the Company’s financial

S&P MD&A Q2_2019-Eng Ref. POL. 085/2019 August 8th 2019 Re: Clarification of the Performance of S & P Syndicate Public Company Limited Dear The President The Stock Exchange of Thailand S & P